Lawlor Augustine Insider Trades

Insider Trading History

Track insider trading activity for Lawlor Augustine. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
PainReform
PainReform PRFX
Director
Holding Value $0 0 shares
Last Trade
Mar 18, 2026 Sale
$439 183 shares
$2.40
$1.86
PainReform
PainReform PRFX
Director
Holding Value $0 0 shares
Last Trade
Mar 18, 2026 Sale
$120 50 shares
$2.40
$1.86
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $21.2k 27,586 shares
Last Trade
Mar 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.12k 22,500 shares
$0.32
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $15.2k 19,789 shares
Last Trade
Mar 28, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.5k 7,797 shares
$0.32
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Mar 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.12k 22,500 shares
$0.32
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $522k 678,456 shares
Last Trade
Nov 13, 2024 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$6.02k 2,136 shares
$2.82
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Nov 13, 2024 Sale (In The Money)Reported as In The Money on SEC Form 4.
$6.02k 2,136 shares
$2.82
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $65.4k 85,000 shares
Last Trade
Oct 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$208k 85,000 shares
$2.45
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $65.4k 85,000 shares
Last Trade
Jan 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$228k 85,000 shares
$2.68
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $3.91k 5,086 shares
Last Trade
Jan 26, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2k 5,000 shares
$2.44
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Jan 26, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2k 5,000 shares
$2.44
$0.77
Catalyst Biosciences
Catalyst Biosciences CBIO
Director
Holding Value $0 0 shares
Last Trade
Aug 31, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$13.4 24 shares
$0.56
$17.98
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $53.9k 70,000 shares
Last Trade
Aug 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$155k 70,000 shares
$2.21
$0.77
Cardiovascular Systems
Cardiovascular Systems CSII
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$506k 25,318 shares
$20.00
$20.00
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $385k 500,000 shares
Last Trade
Mar 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17M 500,000 shares
$34.00
$0.77
Leap Therapeutics
Leap Therapeutics LPTX
Chief Operating Officer
Holding Value $154k 200,000 shares
Last Trade
Sep 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.6M 200,000 shares
$143.00
$0.77
Cardiovascular Systems
Cardiovascular Systems CSII
Director
Holding Value $181k 9,064 shares
Last Trade
Aug 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 9,064 shares
$16.55
$20.00
Leap Therapeutics
Leap Therapeutics LPTX
10% owner, Chief Operating Officer
Holding Value $173k 225,000 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.7M 225,000 shares
$194.00
$0.77
Cardiovascular Systems
Cardiovascular Systems CSII
Director
Holding Value $100k 5,022 shares
Last Trade
Nov 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.6k 1,222 shares
$25.90
$20.00
Leap Therapeutics
Leap Therapeutics LPTX
10% owner, Chief Operating Officer
Holding Value $23.1k 30,000 shares
Last Trade
May 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.86M 30,000 shares
$162.00
$0.77

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up